27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Alnylam Pharmaceuticals (NASDAQ:ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has received FDA approval for the treatment of primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients.
Alnylam Pharmaceuticals is a leader in the study of RNA interference and is attempting to harness this mechanism to create a new class of drugs.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Alnylam Pharmaceuticals shares were trading up 3.23% to $126.99 on Tuesday at the time of publication. The stock has a 52-week high of $167.33 and a 52-week low of $84.97.
Advaxis (NASDAQ:ADXS) shares are trading lower after the company announced a proposed public offering of common stock and warrants to purchase common stock. No terms were disclosed.
Advaxis Inc is a clinical-stage biotechnology company. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.
Advaxis shares were trading down 27.02% to 28 cents. The stock has a 52-week high of $1.48 and a 52-week low of 26 cents.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) shares are trading lower after the company reported FY20 EPS and sales were down year over year.
Arrowhead's main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Arrowhead Pharmaceuticals shares were trading down 12.73% to $59.52. The stock has a 52-week high of $73.72 and a 52-week low of$19.51.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.